2026-05-29
HIRA Quality Assessment: Grade 1 for ‘Breast Cancer’ and Excellent for ‘Liver Cancer’!
Gangneung Asan Hospital achieved Grade 1 for breast cancer for the 8th consecutive time and excellent results for liver cancer in the HIRA quality assessment.
Gangneung Asan Hospital News: HIRA Quality Assessment ‘Breast Cancer’ Grade 1, ‘Liver Cancer’ Excellent!
Gangneung Asan Hospital has achieved Grade 1 for the 8th consecutive time in the ‘2nd Cycle 1st Breast Cancer and Liver Cancer Quality Assessment’ conducted by the Health Insurance Review and Assessment Service (HIRA)!🏆
The hospital also proved its capabilities in treating severe cancers by achieving excellent results in key evaluation indicators for liver cancer.🥳👏
This assessment was conducted on breast and liver cancer patients treated throughout 2023. While specific grades for liver cancer were not calculated due to the characteristics of newly introduced indicators, Gangneung Asan Hospital recorded high performance well above the overall average.
Notably, the hospital recorded a 0% surgical mortality rate for both breast and liver cancer, demonstrating its strength as a tertiary general hospital that prioritizes patient safety above all else!✨
Frequently Asked Questions
What are the results of Gangneung Asan Hospital's breast cancer adequacy assessment?
Yes, we achieved Grade 1 for 8 consecutive times. We proved our high-level cancer treatment capabilities by obtaining the highest grade in the 1st cycle 2nd period breast cancer adequacy assessment organized by the Health Insurance Review and Assessment Service.
Did you also receive Grade 1 in the liver cancer adequacy assessment?
Due to the characteristics of newly introduced indicators for liver cancer, a grade was not calculated in this assessment. However, we recorded excellent results exceeding the overall average in major evaluation indicators, recognizing our expertise in treating severe cancer.
Which period of medical treatment was covered by this adequacy assessment?
It was conducted for patients who received medical treatment throughout 2023. The Health Insurance Review and Assessment Service conducted the evaluation based on data from patients who received treatment for breast cancer and liver cancer in 2023.
What is the mortality rate for breast cancer and liver cancer surgeries?
Both diseases recorded a surgical mortality rate of 0%. This result shows that Gangneung Asan Hospital, as a tertiary general hospital that prioritizes patient safety, performs very safe and professional surgeries.